These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15134245)

  • 21. The impact of generic substitution on price competition in Finland.
    Aalto-Setälä V
    Eur J Health Econ; 2008 May; 9(2):185-91. PubMed ID: 17508226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pricing and reimbursement of in-patent drugs in seven European countries: a comparative analysis.
    Garattini L; Cornago D; De Compadri P
    Health Policy; 2007 Aug; 82(3):330-9. PubMed ID: 17125881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [State of unmet medical needs in France in 2006: necessity of reinforcing research effort].
    Jouan-Flahault C; Billon N; Castaigne A; Henry YD; Omnes C; Puech A; Rosilio M; Lassale C
    Therapie; 2007; 62(5):393-415. PubMed ID: 18206102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delivering generics without regulatory incentives? Empirical evidence from French general practitioners about willingness to prescribe international non-proprietary names.
    Paraponaris A; Verger P; Desquins B; Villani P; Bouvenot G; Rochaix L; Gourheux JC; Moatti JP;
    Health Policy; 2004 Oct; 70(1):23-32. PubMed ID: 15312707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medicaid drug system, AWP policies are 'broken'.
    Med Health; 2005 Jul; 59(23):4. PubMed ID: 16104107
    [No Abstract]   [Full Text] [Related]  

  • 26. Repeat prescriptions: refill adherence in relation to patient and prescriber characteristics, reimbursement level and type of medication.
    Andersson K; Melander A; Svensson C; Lind O; Nilsson JL
    Eur J Public Health; 2005 Dec; 15(6):621-6. PubMed ID: 16126746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Changes of drug reimbursement expenses incurred by National Health Fund in Silesian voivodeship in the period of 1999-2004].
    Swistak P; Dzielicki M; Janiec R; Błońska-Fajfrowska B
    Wiad Lek; 2005; 58(9-10):495-9. PubMed ID: 16529058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prescribing and dispensing generic drugs in the Mambéré-Kadéï health district of the Central African Republic].
    Mouala C; Abeye J; Somse P; Maritoux J; Goumba A
    Med Trop (Mars); 2008 Apr; 68(2):149-54. PubMed ID: 18630047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attitudes of Slovene general practitioners towards generic drug prescribing and comparison with international studies.
    Kersnik J; Peklar J
    J Clin Pharm Ther; 2006 Dec; 31(6):577-83. PubMed ID: 17176362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Medical experts groups and choice of medications. A fair prioritization process guarantees the reliability of the choice of medications].
    Garpenby P
    Lakartidningen; 2004 Aug; 101(32-33):2480-2, 2484. PubMed ID: 15346621
    [No Abstract]   [Full Text] [Related]  

  • 31. Current approaches to the use of generic antiepileptic drugs.
    Krämer G; Biraben A; Carreno M; Guekht A; de Haan GJ; Jedrzejczak J; Josephs D; van Rijckevorsel K; Zaccara G
    Epilepsy Behav; 2007 Aug; 11(1):46-52. PubMed ID: 17537678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safe prescribing.
    Bhanji N
    CMAJ; 2007 Jan; 176(1):66; author reply 66-7. PubMed ID: 17200397
    [No Abstract]   [Full Text] [Related]  

  • 33. The importance of brand continuity in epilepsy drugs.
    Goodwin M
    Nurs Times; 2005 Jun 21-27; 101(25):26-7. PubMed ID: 15997944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Legal regulations towards generic medications].
    Boillat S
    Rev Med Suisse; 2007 Mar; 3(104):828-30. PubMed ID: 17503721
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pharmacists want to assume penalty].
    MMW Fortschr Med; 2006 May; 148(20):55. PubMed ID: 16805194
    [No Abstract]   [Full Text] [Related]  

  • 36. Out-of-pocket costs to users: medicine options for hypertension.
    Arredondo A
    Am J Hypertens; 2008 May; 21(5):492. PubMed ID: 18437138
    [No Abstract]   [Full Text] [Related]  

  • 37. [Influence of the reimbursement scheme on the consumption of drugs].
    Madsen UK
    Ugeskr Laeger; 2009 Mar; 171(10):783-6. PubMed ID: 19265600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions.
    Shrank WH; Hoang T; Ettner SL; Glassman PA; Nair K; DeLapp D; Dirstine J; Avorn J; Asch SM
    Arch Intern Med; 2006 Feb; 166(3):332-7. PubMed ID: 16476874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug importation and safety of drugs obtained from Canada.
    Shepherd M
    Ann Pharmacother; 2007 Jul; 41(7):1288-91. PubMed ID: 17578879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prior authorization made easier.
    Terry K
    Med Econ; 2007 Oct; 84(20):34, 38, 40. PubMed ID: 18075056
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.